SRPT Earnings Sarepta Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 2.88 | 2026-05-06 | 10-Q |
| FY 2025 | 2025-12-31 | -7.13 | 2026-03-02 | 10-K |
| FY 2025 | 2025-09-30 | -0.50 | 2026-03-02 | 10-K |
| FY 2025 | 2025-06-30 | 1.89 | 2026-03-02 | 10-K |
| Q1 2026 | 2025-03-31 | -4.60 | 2026-05-06 | 10-Q |
| FY 2025 | 2024-12-31 | 2.34 | 2026-03-02 | 10-K |
| FY 2025 | 2024-09-30 | 0.34 | 2026-03-02 | 10-K |
| FY 2025 | 2024-06-30 | 0.07 | 2026-03-02 | 10-K |
| FY 2025 | 2024-03-31 | 0.37 | 2026-03-02 | 10-K |
| FY 2025 | 2023-12-31 | -5.80 | 2026-03-02 | 10-K |
| Q3 2024 | 2023-09-30 | -6.56 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-06-30 | -6.11 | 2024-08-07 | 10-Q |
| Q1 2024 | 2023-03-31 | -5.86 | 2024-05-01 | 10-Q |
| FY 2024 | 2022-12-31 | -8.03 | 2025-02-28 | 10-K |
| Q3 2023 | 2022-09-30 | -6.79 | 2023-11-01 | 10-Q |
| Q2 2023 | 2022-06-30 | -3.85 | 2023-08-02 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.20 | 2023-05-02 | 10-Q |
| FY 2023 | 2021-12-31 | -5.15 | 2024-02-28 | 10-K |
| Q3 2022 | 2021-09-30 | -3.72 | 2022-11-02 | 10-Q |
| Q2 2022 | 2021-06-30 | -3.12 | 2022-08-02 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.